
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.145 | -3.7084398977 | 3.91 | 4.1204 | 3.765 | 5428 | 3.94077072 | CS |
4 | -0.2506 | -6.24066142046 | 4.0156 | 4.32 | 3.765 | 4552 | 4.02377598 | CS |
12 | -0.485 | -11.4117647059 | 4.25 | 4.34 | 3.765 | 7054 | 4.12700182 | CS |
26 | -0.075 | -1.953125 | 3.84 | 5.0899 | 3.5601 | 15993 | 4.07501467 | CS |
52 | -0.415 | -9.92822966507 | 4.18 | 5.2 | 2.78 | 12488 | 4.00707762 | CS |
156 | -5.335 | -58.6263736264 | 9.1 | 12.5 | 2.40101 | 40506 | 6.666392 | CS |
260 | -5.018 | -57.1330980303 | 8.783 | 58.5 | 2.40101 | 814606 | 28.24119641 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions